Liu, R., Ji, Z., Wang, X. (2026). Phase Ib/II clinical study of adebrelimab combined with decitabine, nab-paclitaxel, and gemcitabine as first-line (IL) treatment for metastatic pancreatic cancer (mPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4200